🌐🩸 Dedicated to supporting hematology education through accessible knowledge and clinical expertise.

Learn more: hemehub.org

#Hematology #HemeOnc #MedEd #HemeHub #TexasOncology #UPA #WhiteTulipHealthFoundation @ash.edu.hematology.org @isbt.bsky.social @bsochaem.bsky.social @htrstoday.bsky.social

🌍 Expanding access to #hematology education through shared knowledge and clinical insights.

Learn more: hemehub.org

#HemeOnc #MedEd #HemeHub #TexasOncology #UPA #WhiteTulipHealthFoundation

@bsochaem.bsky.social @isbt.bsky.social @ash.edu.hematology.org @ash.hematology.org

🩸 Empowering the future of hematology through collaboration, education, and shared expertise.

🌐 Discover more: hemehub.org

#Hematology #MedEd #ClinicalEducation #HemeHub #HemeOnc #MedicalEducation #Collaboration #TexasOncology #UPA #WhiteTulipHealthFoundation

🩸Advancing hematology education through collaboration and shared expertise.

🌐 Learn more: hemehub.org

#Hematology #MedEd #ClinicalEducation #HemeHub #HemeOnc #ClinicalLearning #Partnerships #TexasOncology #UPA #WhitetulipHealthFoundation

🩸 Advancing hematology education together!

Committed to sharing expertise and fostering knowledge through collaboration and learning.

🌐 Explore more: hemehub.org

#Hematology #MedEd #ClinicalEducation #HemeHub #ClinicalLearning #Partnerships #TexasOncology #UPA #WhitetulipHealthFoundation

At 45, Bryan was diagnosed with advanced prostate cancer.
A BRCA mutation led him to a clinical trial through SCRI at Texas Oncology.
Today, his PSA levels are undetectable—and he’s thriving. 💙
#ProstateCancer #BRCA #SCRI #TexasOncology #USOncologyNetwork #ClinicalTrials #CancerResearch

forward, I’ve been referred to a #hematologist at #TexasOncology for further testing bc we now must eliminate the possibility that an adverse reaction like blood & bone marrow disorders/cancers haven’t developed as a result of Ocrevus treatment before we can confirm the possibility of Late Onset 6/🧡